id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-351002-msjurww1	Ouanes, Y.	Does BCG protect against SARS-CoV-2 infection ?: elements of proof.	2020-05-06		.txt	text/plain	2997	185	53	Results : Countries that never had universal BCG vaccination policy have a higher mortality (correlated to performed diagnostic tests) attributed to SARS-CoV-2 infection (p<0.001). Countries that never had universal BCG vaccination policy have a higher mortality (correlated to performed diagnostic tests) attributed to SARS-CoV-2 infection (p<0.001). For countries that started the BCG vaccination after 1960, countries with current policies have lower mortality attributed to SARS-CoV-2 infection than countries that have stopped immunization (p=0.047). For countries that started the BCG vaccination after 1960, countries with current policies have lower mortality attributed to SARS-CoV-2 infection than countries that have stopped immunization (p=0.047). Based on these observations, we hypothesized that countries which have an early start of universal BCG vaccination policy would have a reduced morbidity and mortality attributed to SARS-CoV-2 infection. Or results revealed that countries that never had universal BCG vaccination policy have a higher mortality (correlated to performed diagnostic tests) attributed to SARS-CoV-2 infection.	./cache/cord-351002-msjurww1.txt	./txt/cord-351002-msjurww1.txt